Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2082716 | Drug Discovery Today: Technologies | 2006 | 7 Pages |
Abstract
Although the term virtual screening as the in silico analog of high throughput screening has been coined only a decade ago, virtual screening is now a widespread lead identification method in the pharmaceutical industry. A myriad of different methods have been developed exploiting the growing library of target structures and assay data as a basis for finding new lead structures. Exploiting synergies between different methods best utilizes the information available and is at the center of recent developments.
Section editors:Tudor Oprea – University of New Mexico, School of Medicine, Albuquerque, USAAlex Tropsha – University of North Carolina, Chapel Hill, USA
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Ingo Muegge, Scott Oloff,